Volume 25, Number 10—October 2019
CME ACTIVITY - Synopsis
Edwardsiella tarda Bacteremia, Okayama, Japan, 2005–2016
Shinya Kamiyama
, Akira Kuriyama, and Toru Hashimoto
, Akira Kuriyama, and Toru Hashimoto
Table 3
Comparison of characteristics of patients with bacteremic and nonbacteremic Edwardsiella tarda infection, Kurashiki Central Hospital, Okayama, Japan, 2005–2016*
| Patient characteristic | Patients with bacteremic infection, n = 26 | Patients with nonbacteremic infection, n = 124 | p value |
|---|---|---|---|
| Median age, y (IQR) [range] |
75 (63–85) [45–101] |
56 (12–73) [0- 89] |
<0.001 |
| Sex, no. patients | |||
| M | 13 | 82 | 0.178 |
| F |
13 |
42 |
|
| Underlying disease, no. patients | |||
| Solid tumor | 12 | 22 | 0.004 |
| Cardiovascular disease | 4 | 22 | 1.00 |
| Diabetes mellitus | 3 | 13 | 1.00 |
| Gallstone | 3 | 13 | 1.00 |
| Chronic liver disease | 2 | 7 | 0.65 |
| Cerebrovascular disease | 2 | 1 | 0.078 |
| Hematologic malignancy | 1 | 1 | 0.32 |
| Chronic kidney disease | 0 | 1 | 1.00 |
| Ulcerative colitis | 0 | 14 | 0.13 |
| Crohn disease | 0 | 1 | 1.00 |
| None | 4 | 52 | 0.013 |
| Other |
0 |
2 |
1.00 |
| Behavioral/dietary risk factors, no. patients | |||
| Alcoholism | 4 | 9 | 0.24 |
| Exposure to raw food | 3 | 7 | 0.38 |
| Exposure to fresh or marine water, animal feces |
1 |
0 |
0.173 |
| Clinical diagnosis, no. patients | |||
| Cholangitis | 9 | 8 | <0.001 |
| Liver abscess | 6 | 1 | <0.001 |
| Enterocolitis | 4 | 74 | 0.076 |
| Cholecystitis | 3 | 9 | 0.44 |
| Spontaneous bacterial peritonitis | 1 | 0 | 0.173 |
| Mycotic aneurysm | 1 | 1 | 0.32 |
| Necrotizing fasciitis | 1 | 0 | 0.173 |
| Empyema | 1 | 0 | 0.173 |
| Febrile neutropenia | 1 | 0 | 0.173 |
| Osteomyelitis | 1 | 0 | 0.173 |
| Secondary peritonitis | 1 | 0 | 0.173 |
| Focus unknown | 5 | 1 | 0.001 |
| Endometriosis | 0 | 1 | 1.00 |
| Appendicitis | 0 | 4 | 1.00 |
| Congenital infection | 0 | 1 | 1.00 |
| Cystitis | 0 | 1 | 1.00 |
| Intraabdominal abscess | 0 | 1 | 1.00 |
| Perianal abscess | 0 | 1 | 1.00 |
| Pneumonia | 0 | 2 | 1.00 |
| Pyometra | 0 | 1 | 1.00 |
| Secondary peritonitis | 0 | 2 | 1.00 |
| Superficial surgical site infection |
0 |
1 |
1.00 |
| Receipt of chemotherapy for cancer, no. patients |
4 |
7 |
0.099 |
| Median duration of treatment for infection, d (IQR) [range] | 12 (7–27) [1–77] | 5 (3–9) [0–36] | <0.001 |
*IQR, interquartile range.
Page created: September 12, 2019
Page updated: September 12, 2019
Page reviewed: September 12, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.